Pharmaceutical stocks to draw growing buy interest

Despite the prevailing view that Korean companies can no longer expect success only by depending on making generic drugs in an era of the Korea-U.S. FTA, pharmaceutical stocks of major drug makers will increase gains, analysts said recently.

Analysts said that the outlook for the domestic pharmaceutical industry is relatively cloudy as the FTA allows U.S. firms to set up an independent revie...